Stem Cells, Vol 13, 622-639, Copyright © 1995 by AlphaMed Press

REVIEWS

Microchimerism, dendritic cell progenitors and transplantation tolerance

AW Thomson, L Lu, N Murase, AJ Demetris, AS Rao and TE Starzl
Pittsburgh Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania 15213, USA.

The recent discovery of multilineage donor leukocyte microchimerism in allograft recipients up to three decades after organ transplantation implies the migration and survival of donor stem cells within the host. It has been postulated that in chimeric graft recipients, reciprocal modulation of immune responsiveness between donor and recipient leukocytes may lead, eventually, to the induction of mutual immunologic nonreactivity (tolerance). A prominent donor leukocyte, both in human organ transplant recipients and in animals, has invariably been the bone marrow-derived dendritic cell (DC). These cells have been classically perceived as the most potent antigen-presenting cells but evidence also exists for their tolerogenicity. The liver, despite its comparatively heavy leukocyte content, is the whole organ that is most capable of inducing tolerance. We have observed that DC progenitors propagated from normal mouse liver in response to GM-CSF express only low levels of major histocompatibility complex (MHC) class II antigen and little or no cell surface B7 family T cell costimulatory molecules. They fail to activate resting naive allogeneic T cells. When injected into normal allogeneic recipients, these DC progenitors migrate to T- dependent areas of host lymphoid tissue, where some at least upregulate cell surface MHC class II. These donor-derived cells persist indefinitely, recapitulating the behavior pattern of donor leukocytes after the successful transplantation of all whole organs, but most dramatically after the orthotopic (replacement) engraftment of the liver. A key finding is that in mice, progeny of these donor-derived DC progenitors can be propagated ex vivo from the bone marrow and other lymphoid tissues of nonimmunosuppressed spontaneously tolerant liver allograft recipients. In humans, donor DC can also be grown from the blood of organ allograft recipients whose organ-source chimerism is augmented with donor bone marrow infusion. DC progenitors cannot, however, be propagated from the lymphoid tissue of nonimmunosuppressed cardiac-allografted mice that reject their grafts. These findings are congruent with the possibility that bidirectional leukocyte migration and donor cell chimerism play key roles in acquired transplantation tolerance. Although the cell interactions are undoubtedly complex, a discrete role can be identified for DC under well-defined experimental conditions. Bone marrow-derived DC progenitors (MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness (anergy) in naive T cells in vitro. Moreover, costimulatory molecule-deficient DC progenitors administered systemically prolong the survival of mouse heart or pancreatic islet allografts. How the regulation of donor DC phenotype and function relates to the balance between the immunogenicity and tolerogenicity of organ allografts remains to be determined.

This article has been cited by other articles:

				M.-S. Yoon, J. S. Lee, B.-M. Choi, Y.-I. Jeong, C.-M. Lee, J.-H. Park, Y. Moon, S.-C. Sung, S. K. Lee, Y. H. Chang, et al. Apigenin Inhibits Immunostimulatory Function of Dendritic Cells: Implication of Immunotherapeutic Adjuvant Mol. Pharmacol., September 1, 2006; 70(3): 1033 - 1044. [Abstract] [Full Text] [PDF]

				M. Raghavan and P. E. Marik Anemia, Allogenic Blood Transfusion, and Immunomodulation in the Critically Ill Chest, January 1, 2005; 127(1): 295 - 307. [Abstract] [Full Text] [PDF]

				M. R. Dana Corneal Antigen-Presenting Cells: Diversity, Plasticity, and Disguise The Cogan Lecture Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 722 - 727. [Full Text] [PDF]

				E. J. Abraham, S. Kodama, J. C. Lin, M. Ubeda, D. L. Faustman, and J. F. Habener Human Pancreatic Islet-Derived Progenitor Cell Engraftment in Immunocompetent Mice Am. J. Pathol., March 1, 2004; 164(3): 817 - 830. [Abstract] [Full Text] [PDF]

				P. Hamrah, S. O. Huq, Y. Liu, Q. Zhang, and M. R. Dana Corneal immunity is mediated by heterogeneous population of antigen-presenting cells J. Leukoc. Biol., August 1, 2003; 74(2): 172 - 178. [Abstract] [Full Text] [PDF]

				P. Hamrah, Y. Liu, Q. Zhang, and M. R. Dana Alterations in Corneal Stromal Dendritic Cell Phenotype and Distribution in Inflammation Arch Ophthalmol, August 1, 2003; 121(8): 1132 - 1140. [Abstract] [Full Text] [PDF]

				P. Hamrah, Y. Liu, Q. Zhang, and M. R. Dana The Corneal Stroma Is Endowed with a Significant Number of Resident Dendritic Cells Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 581 - 589. [Abstract] [Full Text] [PDF]

				A H Lau and A W Thomson Dendritic cells and immune regulation in the liver Gut, February 1, 2003; 52(2): 307 - 314. [Abstract] [Full Text] [PDF]

				W.-P. Min, D. Zhou, T. E. Ichim, G. H. Strejan, X. Xia, J. Yang, X. Huang, B. Garcia, D. White, P. Dutartre, et al. Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance J. Immunol., February 1, 2003; 170(3): 1304 - 1312. [Abstract] [Full Text] [PDF]

				P. Hamrah, Q. Zhang, Y. Liu, and M. R. Dana Novel Characterization of MHC Class II-Negative Population of Resident Corneal Langerhans Cell-Type Dendritic Cells Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 639 - 646. [Abstract] [Full Text] [PDF]

				Y. Bai, J. Liu, Y. Wang, S. Honig, L. Qin, P. Boros, and J. S. Bromberg L-Selectin-Dependent Lymphoid Occupancy Is Required to Induce Alloantigen-Specific Tolerance J. Immunol., February 15, 2002; 168(4): 1579 - 1589. [Abstract] [Full Text] [PDF]

				Y. Liu, P. Hamrah, Q. Zhang, A. W. Taylor, and M. R. Dana Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II-positive Dendritic Cells Derived from MHC Class II-negative Grafts J. Exp. Med., January 22, 2002; 195(2): 259 - 268. [Abstract] [Full Text] [PDF]

				W. Li, L. Lu, Z. Wang, L. Wang, J. J. Fung, A. W. Thomson, and S. Qian IL-12 Antagonism Enhances Apoptotic Death of T Cells Within Hepatic Allografts from Flt3 Ligand-Treated Donors and Promotes Graft Acceptance J. Immunol., May 1, 2001; 166(9): 5619 - 5628. [Abstract] [Full Text] [PDF]

				P. A Fontes and A. W Thomson Stem cell technology BMJ, November 13, 1999; 319(7220): 1308 - 1308. [Full Text]

				R. Josien, M. Heslan, S. Brouard, J.-P. Soulillou, and M.-C. Cuturi Critical Requirement for Graft Passenger Leukocytes in Allograft Tolerance Induced by Donor Blood Transfusion Blood, December 15, 1998; 92(12): 4539 - 4544. [Abstract] [Full Text] [PDF]

				J. L. Viney, A. M. Mowat, J. M. O'Malley, E. Williamson, and N. A. Fanger Expanding Dendritic Cells In Vivo Enhances the Induction of Oral Tolerance J. Immunol., June 15, 1998; 160(12): 5815 - 5825. [Abstract] [Full Text] [PDF]

				M. A. Antonysamy, R. J. Steptoe, A. Khanna, W. A. Rudert, V. M. Subbotin, and A. W. Thomson Flt-3 Ligand Increases Microchimerism But Can Prevent the Therapeutic Effect of Donor Bone Marrow in Transiently Immunosuppressed Cardiac Allograft Recipients J. Immunol., April 15, 1998; 160(8): 4106 - 4113. [Abstract] [Full Text] [PDF]

				S. D. Lyman and S. E. W. Jacobsen c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities Blood, February 15, 1998; 91(4): 1101 - 1134. [Full Text] [PDF]